Metered Dose Inhalers: A small aerosol canister used to release a calibrated amount of medication for inhalation.Nebulizers and Vaporizers: Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments.Dry Powder Inhalers: A device that delivers medication to the lungs in the form of a dry powder.Administration, Inhalation: The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract.Bronchodilator Agents: Agents that cause an increase in the expansion of a bronchus or bronchial tubes.Powders: Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed)Chlorofluorocarbons: A series of hydrocarbons containing both chlorine and fluorine. These have been used as refrigerants, blowing agents, cleaning fluids, solvents, and as fire extinguishing agents. They have been shown to cause stratospheric ozone depletion and have been banned for many uses.Aerosol Propellants: Compressed gases or vapors in a container which, upon release of pressure and expansion through a valve, carry another substance from the container. They are used for cosmetics, household cleaners, and so on. Examples are BUTANES; CARBON DIOXIDE; FLUOROCARBONS; NITROGEN; and PROPANE. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)Aerosols: Colloids with a gaseous dispersing phase and either liquid (fog) or solid (smoke) dispersed phase; used in fumigation or in inhalation therapy; may contain propellant agents.Anti-Asthmatic Agents: Drugs that are used to treat asthma.Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.Beclomethasone: An anti-inflammatory, synthetic glucocorticoid. It is used topically as an anti-inflammatory agent and in aerosol form for the treatment of ASTHMA.Equipment Design: Methods of creating machines and devices.Inhalation Spacers: A variety of devices used in conjunction with METERED DOSE INHALERS. Their purpose is to hold the released medication for inhalation and make it easy for the patients to inhale the metered dose of medication into their lungs.Fenoterol: An adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.Ipratropium: A muscarinic antagonist structurally related to ATROPINE but often considered safer and more effective for inhalation use. It is used for various bronchial disorders, in rhinitis, and as an antiarrhythmic.Hydrocarbons, FluorinatedBudesonide: A glucocorticoid used in the management of ASTHMA, the treatment of various skin disorders, and allergic RHINITIS.Peak Expiratory Flow Rate: Measurement of the maximum rate of airflow attained during a FORCED VITAL CAPACITY determination. Common abbreviations are PEFR and PFR.Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.Respiratory System Agents: Drugs used for their effects on the respiratory system.Adrenergic beta-Agonists: Drugs that selectively bind to and activate beta-adrenergic receptors.Ethanolamines: AMINO ALCOHOLS containing the ETHANOLAMINE; (-NH2CH2CHOH) group and its derivatives.Pregnenediones: Unsaturated pregnane derivatives containing two keto groups on side chains or ring structures.Forced Expiratory Volume: Measure of the maximum amount of air that can be expelled in a given number of seconds during a FORCED VITAL CAPACITY determination . It is usually given as FEV followed by a subscript indicating the number of seconds over which the measurement is made, although it is sometimes given as a percentage of forced vital capacity.Chlorofluorocarbons, Methane: A group of methane-based halogenated hydrocarbons containing one or more fluorine and chlorine atoms.Technology Assessment, Biomedical: Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems.Cross-Over Studies: Studies comparing two or more treatments or interventions in which the subjects or patients, upon completion of the course of one treatment, are switched to another. In the case of two treatments, A and B, half the subjects are randomly allocated to receive these in the order A, B and half to receive them in the order B, A. A criticism of this design is that effects of the first treatment may carry over into the period when the second is given. (Last, A Dictionary of Epidemiology, 2d ed)Double-Blind Method: A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.Hoarseness: An unnaturally deep or rough quality of voice.Androstadienes: Derivatives of the steroid androstane having two double bonds at any site in any of the rings.Atropine Derivatives: Analogs and derivatives of atropine.Vital Capacity: The volume of air that is exhaled by a maximal expiration following a maximal inspiration.Particle Size: Relating to the size of solids.Cromolyn Sodium: A chromone complex that acts by inhibiting the release of chemical mediators from sensitized mast cells. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack.Pregnadienediols: Doubly unsaturated pregnane derivatives with two hydroxy groups substituted anywhere on the rings or side chains.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Lung: Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.Drug Delivery Systems: Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity.Respiratory Therapy: Care of patients with deficiencies and abnormalities associated with the cardiopulmonary system. It includes the therapeutic use of medical gases and their administrative apparatus, environmental control systems, humidification, aerosols, ventilatory support, bronchopulmonary drainage and exercise, respiratory rehabilitation, assistance with cardiopulmonary resuscitation, and maintenance of natural, artificial, and mechanical airways.Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.Chemistry, Pharmaceutical: Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use.Technetium: The first artificially produced element and a radioactive fission product of URANIUM. Technetium has the atomic symbol Tc, atomic number 43, and atomic weight 98.91. All technetium isotopes are radioactive. Technetium 99m (m=metastable) which is the decay product of Molybdenum 99, has a half-life of about 6 hours and is used diagnostically as a radioactive imaging agent. Technetium 99 which is a decay product of technetium 99m, has a half-life of 210,000 years.Technology, Pharmaceutical: The application of scientific knowledge or technology to pharmacy and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures, and in the treatment of patients.Randomized Controlled Trials as Topic: Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.Biological Availability: The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action.Glucocorticoids: A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system.Scopolamine Derivatives: Analogs or derivatives of scopolamine.Adrenal Cortex HormonesDrug Administration Schedule: Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.Patient Education as Topic: The teaching or training of patients concerning their own health needs.Device Approval: Process that is gone through in order for a device to receive approval by a government regulatory agency. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance. It is not restricted to FDA.Anti-Inflammatory Agents: Substances that reduce or suppress INFLAMMATION.Drug Combinations: Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.Hydrocortisone: The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.Therapeutic Equivalency: The relative equivalency in the efficacy of different modes of treatment of a disease, most often used to compare the efficacy of different pharmaceuticals to treat a given disease.Adrenergic beta-2 Receptor Agonists: Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS.Equipment Safety: Freedom of equipment from actual or potential hazards.Patient Compliance: Voluntary cooperation of the patient in following a prescribed regimen.Cholinergic Antagonists: Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists.Equipment Failure: Failure of equipment to perform to standard. The failure may be due to defects or improper use.Dose-Response Relationship, Drug: The relationship between the dose of an administered drug and the response of the organism to the drug.Inspiratory Capacity: The maximum volume of air that can be inspired after reaching the end of a normal, quiet expiration. It is the sum of the TIDAL VOLUME and the INSPIRATORY RESERVE VOLUME. Common abbreviation is IC.Maximal Expiratory Flow Rate: The airflow rate measured during the first liter expired after the first 200 ml have been exhausted during a FORCED VITAL CAPACITY determination. Common abbreviations are MEFR, FEF 200-1200, and FEF 0.2-1.2.Self Administration: Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal.Bronchi: The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI.Respiratory Function Tests: Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc.Ozone Depletion: A shift in the balance between production and destruction of STRATOSPHERIC OZONE that results in a decline of the amount of OZONE in the lower stratosphere.Patient Preference: Individual's expression of desirability or value of one course of action, outcome, or selection in contrast to others.Drug Therapy, Combination: Therapy with two or more separate preparations given for a combined effect.Bronchial Spasm: Spasmodic contraction of the smooth muscle of the bronchi.Intrauterine Devices: Contraceptive devices placed high in the uterine fundus.Medication Adherence: Voluntary cooperation of the patient in taking drugs or medicine as prescribed. This includes timing, dosage, and frequency.
  • Telehealth Ready: Performance of the Amiko Respiro Sense connected technology with Merxin DPIs": connected devices have been proven to improve compliance of patients and help them manage their therapies. (slideshare.net)
  • Our DPIs have been developed to ensure consistent dose delivery through patient-friendly devices - Rotacaps and Multi-halers comprising the actives and a high grade excipient. (cipla.com)
  • Addition to this, the global Respiratory Inhaler market serves major top players AstraZeneca Plc. (pharmiweb.com)
  • North America market is expected to dominate the global respiratory inhaler market, and it accounts for largest market revenue share of 34.3% in 2020 as compared to that of markets in other regions. (pharmiweb.com)
  • The global Respiratory Inhaler market has highlights on each and every region intensely to comprehend the overview related to different manufacturer at small scale and large scale level. (pharmiweb.com)
  • In terms of value, the global respiratory inhaler devices market is projected to register a healthy CAGR of 4.3% during the forecast period due to various factors. (openpr.com)
  • The metered dose inhaler segment is estimated to account for maximum share in the global respiratory inhaler devices market by 2015 end, and expected to register a CAGR of 4.5% in terms of value during the forecast period 2015-2025. (openpr.com)
  • Examples of inhalers in this category include Flovent (fluticasone), Beclovent/Qvar (beclomethasone), Aerobid/Aerospan (flunisolide), and Pulmicort (budesonide). (verywellhealth.com)
  • it is not available in a lower strength product containing salmeterol 25 microgram and fluticasone propionate 50 microgram, a strength which is available for other similar fixed-dose combination products containing these two actives and currently available on the market. (medicines.org.uk)
  • Therefore, when it is appropriate to titrate down to a dose of inhaled glucocorticosteroid below 125 micrograms, a change to an alternative fixed-dose combination of salmeterol and fluticasone propionate containing a lower dose of the inhaled glucocorticosteroid is required. (medicines.org.uk)
  • In these cases, the recommended initial dose is two inhalations of 25 micrograms salmeterol and 50 micrograms fluticasone propionate twice daily. (medicines.org.uk)
  • Study-1 was single dose, randomized, 4-period, 2‑sequence, laboratory-blinded, crossover, replicate design conducted in 90 healthy volunteers under fasting conditions with concurrent oral charcoal blockade with a washout period of 7-14 days. (omicsonline.org)
  • Study-3 was single dose, randomized, 2-period, 2‑sequence, laboratory-blinded, crossover design conducted in 64 healthy volunteers under fasting conditions with Aero Chamber Plus valved holding chamber with a washout period of 7-10 days. (omicsonline.org)
  • It is used to deliver higher doses of the medicine than a standard inhaler. (netdoctor.co.uk)
  • Study team leader Professor Julian Crane from the University of Otago, Wellington, says the findings are the first evidence that inhaled nicotine from a simple standard inhaler is highly effective and substantially increases a smoker's chances of quitting compared to the best current nicotine replacement treatment. (medicalnewstoday.com)
  • A nicotine inhaler allows cigarette smokers to get nicotine without using tobacco, much like nicotine gum or a nicotine patch. (wikipedia.org)
  • The nicotine inhaler is also temperature sensitive. (wikipedia.org)
  • The Nicotine Inhaler is considered easier to use than the electronic cigarette as it is usually disposable, and contains fewer parts than the electronic cigarette. (wikipedia.org)
  • The evidence suggests that the US Food and Drug Administration (FDA) accepted products such as a nicotine inhaler may be a safer way to give nicotine than e-cigarettes. (wikipedia.org)
  • A study by researchers at New Zealand's University of Otago, Wellington shows that smokers who used a nicotine inhaler were twice as likely to quit smoking as smokers using a placebo inhaler. (medicalnewstoday.com)
  • The researchers developed and tested a novel nicotine inhaler to see whether it helps smokers to quit smoking. (medicalnewstoday.com)
  • Participants in the study were randomly assigned to receive either a nicotine inhaler plus a nicotine patch, or a placebo inhaler plus a nicotine patch. (medicalnewstoday.com)
  • This study shows that if you add a nicotine inhaler to a nicotine patch, it doubles the chances of quitting over a nicotine patch alone," says Professor Crane. (medicalnewstoday.com)
  • The nicotine inhaler gives a metered dose of nicotine and offers an alternative therapeutic option for inhaled nicotine using a standard device that has been used for many decades for treatment of asthma . (medicalnewstoday.com)
  • The pulmonary route by oral inhaler delivery of salbutamol sulphate was considered as another route of non invasive systemic drug delivery method. (ijpsonline.com)
  • In addition, increasing in air pollution, technological advancements, increasing number of product approvals for respiratory inhalers are other factor expected to boost the market growth over the forecast period. (pharmiweb.com)
  • Unfortunately, this passive operation can lead to poor dosing uniformity since inspiratory capabilities can vary from patient to patient (and sometimes even use to use by the same patient, particularly if the patient is undergoing an asthmatic attack or respiratory-type ailment which tends to close the airway). (justia.com)
  • Click on a topic to read articles on airway clearance techniques, nutrition, updates on devices, or advice about CF complications. (stanford.edu)
  • Cipla will soon launch an innovative inhaler which will bring important benefits for physicians, patients and healthcare providers on managing Obstructive Airway Disease (OAD). (cipla.com)